A federal court has thrown out a lawsuit brought by ViroPharma (VPHM +0.2%) against the FDA that...


A federal court has thrown out a lawsuit brought by ViroPharma (VPHM +0.2%) against the FDA that sought to stop the agency from approving three generic versions of the company's antibiotic Vancocin, saying the drug developer failed to produce any new evidence. Vancocin, a treatment for Clostridium difficile and other gastrointestinal infections, accounted for about $289M in VPHM’s sales in 2011, and constitutes about half of its revenue.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs